You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

André de Villers

President at CEMA, Inc.
Overview
Relationships
Paths
Education
Career History
Boards & Committees
Investments

André de Villers

President at CEMA, Inc.

Overview

Notable Companies
CEMA, Inc.

Theratechnologies, Inc.

CelMed BioSciences, Inc.
Board Seats
6
Number of Relationships
This person is connected to 92 people.

Relationships See Details


Founder at Alizé Pharma SAS

Co-Founder at Alizé Pharma SAS

Co-Founder at Alizé Pharma SAS

President & Founder at Orega Biotech SAS

Medical Director at Alizé Pharma SAS

Venture Partner at Ventech SA

Managing Partner at Sofimac Innovation SAS

Senior Investment Director at BPIFrance Investissement SAS

President, Chief Executive Officer & Non-Independent Director at TSO3, Inc.

Co-Founder at TSO3, Inc.
See 82 more listings with RelSci Professional.

Paths to André de Villers

André de Villers
You
Connections via Relationship Science
André de Villers
Sync your contacts to see how you can connect with André de Villers.

Educational Background

Undergraduate Degree 
Class of 1973 
The Université de Montréal is a public research university in Montreal, Quebec, Canada. The francophone institution comprises thirteen faculties, more than sixty departments and two affiliated schools: the École Polytechnique (School of Engineering) and HEC Montréal (School of Business). It offers more than 650 undergraduate programmes and graduate programmes.

Career History

Director
2007 - Current
Alizé Pharma SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.
President
Current
CEMA, Inc. operates as an investment holding company. The company is headquartered in Montreal, Canada.
President & Chief Executive Officer
2004 - 2006
Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada.
President
1993 - 2004
Theratechnologies, Inc. is engaged in the development of therapeutic peptide products. It addresses unmet medical needs in metabolic disorders to promote healthy ageing. Its product EGRIFTA reduces excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montreal, Canada.
Professional
Prior
Professional
Prior
Ecopia is finding novel anticancer therapies from soil-dwelling micro organisms that are as of this day one of the most prolific sources of these drugs. Their current focus is ECO-4601, a new small molecule that crosses the blood brain barrier and is effective in significantly inhibiting primary tumor growth in the brain. Just like well-known chemotherapies such as doxorubicin and daunorubicin, ECO-4601 comes from microorganisms that live in common soil. ECO-4601 represents a new chemical class that is the fruit of a very unique drug discovery platform called the Decipher® technology

Boards & Committees

Corporate Boards ▾
Member, Board of Directors
2007 - Current
Alizé Pharma SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.
Director
Current
Alizé Pharma II SAS engages in the development of biopharmaceutical drugs, proteins and peptides, for the treatment of metabolic diseases and rare diseases. Its lead assets are pegcrisantaspase (Asparec), a PEGylated recombinant L-asparaginase from Erwinia chrysanthemi, and related intellectual property. The company was founded in 2008 and is headquartered in Ecully, France.
Director
Current
Chairman & Chief Executive Officer
2004 - 2006
Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada.
Director
1998 - 2013
TSO3, Inc. engages in the business of medical devices. Its activities include manufacturing, sale; research and development, licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The company was founded by Jocelyn Vézina and Simon Robitaille on June 10, 1998 and is headquartered in Québec, Canada.
Member, Board of Directors
Prior

Investments

Details Hidden
Alizé Pharma SAS provides pharmaceutical research services. It engages in the development of biopharmaceutical drugs, proteins and peptides for the treatment of metabolic diseases and rare diseases. The company was founded by Thierry Abribat, André de Villers, Ezio Ghigo and Aart Jan van der Lely on April 23, 2007 and is headquartered in Ecully, France.

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.